Extramural Funding Opportunities

USU INTRAMURAL COVID-19 RESEARCH FUNDING

There are no internal (USU Intramural) funding opportunities.

EXTRAMURAL RESEARCH INFO & FUNDING OPPORTUNITIES RELATED TO SARS-COV-2/COVID-19

RAPID FUNDING - JUST RELEASED!!

• American Diabetes Association COVID-19 and Diabetes Research Award - The American Diabetes Association (ADA) is requesting applications for research focused on the impact of diabetes on COVID-19 and the impact of COVID-19 on diabetes and its complications. The expedited application deadline will be 5pm ET on May 22, 2020 for July 1, 2020 funding.

Fast-Track Program for COVID-19 Test Development and Distribution

• Rapid Acceleration of Diagnostics (RADx) - Support for the full range of product development including commercialization and product distribution to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests.

OTHER FEDERAL OPPORTUNITIES

• BARDA - 2019 Novel Coronavirus Medical Countermeasure Partnership Opportunities - Including AOIs related to nonclinical models, diagnostic assays, vaccines, therapeutics, pre- and post-exposure prophylaxis, respiratory protective devices, ventilators, and advanced manufacturing technologies.
• CDMRP - Peer Reviewed Medical Program: New Focus Area in Emerging Viral Disease & Respiratory Health  - Clinical Trial, Technology/Therapeutic, and Investigator-Initiated Research Awards with a focus on SARS-CoV-2/COVID-19. No preproposals required.
• PRMRP - Peer Reviewed Medical Research Program - Covid-19 Updates
• NIH - R21 Clinical Trial Not Allowed (PAR-20-177) - The purpose of this Funding Opportunity Announcement (FOA) is to provide an expedited funding mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19).
• NIH - R01 Clinical Trial Not Allowed (PAR-20-178) - The purpose of this Funding Opportunity Announcement (FOA) is to provide an expedited funding mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19).
• NIH - Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Clinical Trial Not Allowed) [PA-19-068] - The purpose of this Funding Opportunity Announcement (FOA) is to support projects that utilize open-access data, alone or in combination with other datasets, to address knowledge gaps in basic and/or clinical research in infectious diseases.
• NIH - Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19) - NCCIH is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 Novel Coronavirus (2019-nCoV, also known as COVID-19). Topics of specific interest for this NOSI include research on stress management strategies, including mind and body approaches, that individuals may engage in remotely to address stressors related to social distancing, as well as to address recovery and recurrence of symptoms during and after COVID-19 infections.
• NIH - Notice of Special Interest (NOSI): National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19) - The National Cancer Institute (NCI) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and the effects of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), on cancer, and vice versa. Topics of specific interest to NCI include understanding the basic mechanisms of interaction between SARS-CoV-2 and cancer cells, co-morbidities of cancer and SARS-CoV-2 infection (especially in disparately affected patient populations), and the impacts on treatment and clinical outcomes of SARS-CoV-2 infected persons in the context of cancer.
• NIH - Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19) - The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Cancer Institute (NCI) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for the development of prophylactic, therapeutic and diagnostic for Coronavirus Disease 2019 (COVID-19). To accelerate the development of promising technologies, the NCI encourages applications from small businesses with NCI-funded active SBIR/STTR awards for technologies that have a strong potential to be adapted/repurposed for use as a prophylactic, therapeutic or diagnostic tool for SARS-CoV-2 (COVID-19).
• NIH - Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) - NIDCD is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) in relation to NIDCD’s scientific mission areas of hearing, balance, taste, smell, voice, speech and language.
• NIH - Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK - NIDDK is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19). NIDDK is particularly interested in projects focusing on the direct action of the virus on kidney, gastrointestinal tract function, and the endocrine/metabolic system, and the collection of biosamples that will inform the understanding of renal, gastrointestinal, and endocrine/metabolic sequelae of viral infection. Pilot clinical studies (observational and interventional) that support the understanding or treatment of COVID-19-related diseases within the mission of the NIDDK are also of interest. NIDDK will only consider applications that propose projects that may lead to rapid translation and impact in the COVID-19 emergency to be responsive to this NOSI.
• NIH - NOT-EB-20-006 Notice of Special Interest (NOSI): Small Business Research and Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) - The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for accelerating the development, translation, and commercialization of technologies to address Coronavirus Disease 2019 (COVID-19). 
• NIH - NOT-EB-20-007 Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) - The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for accelerating the development, translation, and commercialization of technologies to address Coronavirus Disease 2019 (COVID-19).
• NIH - NOT-EB-20-008 Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) - The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for accelerating the development, translation, and commercialization of technologies to address Coronavirus Disease 2019 (COVID-19). 
• NIH - Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) - NIEHS is issuing this Notice of Special Interest (NOSI) to address the urgent need for mission-relevant research to understand the impact of environmental exposures on Coronavirus Disease 2019 (COVID-19) and its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2). NIEHS is particularly interested in applications that will provide insight into the role of environmental exposures in pathogenicity, transmission, individual susceptibility, or prevention and intervention strategies.
• NIH - NIEHS Worker Training Program Coronavirus and Infectious Disease Response Training (Admin Supp Clinical Trial Not Allowed) - The purpose of this supplement is to provide support for the conduct of worker-based training to prevent and reduce exposure of hospital employees, emergency first responders, and other workers who are at risk of exposure to Coronavirus through their work duties. The NIEHS Superfund Worker Training Program (WTP) will work collaboratively to develop and target safety and health training for those workers supporting the national Coronavirus response. 
• NIH - Notice of Special Interest (NOSI): Urgent Competitive Revisions to Accelerate Research on the Development of Predictive Models of the Spread of SARS-CoV-2 and Outcomes of Potential Public Health Interventions on COVID-19 - NIGMS is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on SARS-CoV-2 and Coronavirus Disease 2019 (COVID-19).
• NIH - Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities - The National Institute on Minority Health and Health Disparities (NIMHD) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the impact of the novel Coronavirus (SARS-CoV-2) pandemic causing COVID-19 disease outbreaks and the resulting disruptions on individual and social wellbeing, health services use, and health outcomes for NIH-designated health disparity populations.
• NIH - Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus - NIMH is issuing this Notice of Special Interest (NOSI) to highlight interest in research to strengthen the mental health response to Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and to future public health emergencies, including pandemics. NIMH is especially interested in research to provide an evidence base for how a disrupted workforce may adequately respond/adapt to and maintain services or provide additional care for new or increasing mental health needs, as well as to learn about the effects of the virus and public health measures to prevent spread of COVID-19 that may have an impact on mental health. Research addressing the intersection of COVID-19, mental health, and HIV treatment and prevention are also of interest to NIMH.
• AHRQ (HHS) - RFA-HS-20-003 Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19 - The health systems research community should prepare to submit applications to AHRQ to fund critical research focused on evaluating topics such as innovations and challenges encountered in the rapid expansion of telemedicine in response to COVID-19, effects on quality, safety, and value of health system response to COVID-19, and the role of primary care practices and professionals during the COVID-19 epidemic. 
• USDA - Distance Learning & Telemedicine Grants - Also makes available up to $25 million received from the Coronavirus Aid, Relief, and Economic Security Act (CARES Act).

NON-FEDERAL OPPORTUNITIES

• MTEC - Solicitation Number: MTEC-20-12-COVID-19_Diagnostics “Wearable Diagnostic for Detection of COVID-19 Infection” - The goal of this RPP is to develop a wearable diagnostic capability for the pre-/very earlysymptomatic detection of COVID-19 infection.  
• PFIZER - Pfizer COVID-19 Competitive Grant Program - We are releasing this Request for Proposals (RFP) to provide financial support for organizations producing independent educational programs and quality improvement initiatives designed to combat this evolving crisis. For this RFP, organizations are invited to submit an application addressing the gaps in knowledge and practice of COVID-19 management as outlined in the RFP.
• PCORI - COVID-19 Targeted PFA - The objectives of this announcement are to (1) strengthen the understanding of different approaches to mitigate the impact of COVID-19 on individuals, communities, healthcare providers, and healthcare systems; and (2) provide evidence to inform clinical and public health responses, decision making, and planning.

USU faculty and students are encouraged to apply for extramural funding. This page will be frequently updated to assist with identifying extramural announcements. In addition, USU faculty and students may access the Pivot Funding Database.

Department of Defense (DoD) Research Funding Sponsors

Research Topics are often delineated as follows:

Directed by Congress

• Sometimes called "Congressional Special Interest (CSI)"
• Congressionally Directed Medical Research Program (CDMRP)

Component/Service Specific Calls for Proposals

• Air Force Office of Scientific Research (AFOSR)
• Office of Naval Research (ONR)
• United States Army Medical Department Medical Research and Materiel Command (USAMRMC)
  • Broad Agency Announcements (BAA) - open continuous submission period
  • Intramural DoD - Joint Programmatic Committee (JPC)

Types of Announcements

• BAA - Broad Agency Announcement

Key features: NO set due date

White paper or Letter of Intent (LOI) initial submission

Full Proposal submitted only upon selection

~90 day response time from receipt of white paper/LOI about whether full proposal is solicited.

Typical DoD sponsors that utilize this type of mechanism: USAMRMC, USAMRAA, ONR & AFOSR

PA - Program Announcement

Key Features: Could have multiple specific due dates

Possible Letter of Intent (LOI) requirement, but not always

Full proposal submission is required

Three to four (4) month response time from receipt of full application

Typical DoD Sponsors that utilize this type of mechanism: CDMRP, DTRA, intramural JPC

RFA - Request for Applications

Key Features: Specific due date

Defined research topic area

Full Proposal Submission is required

Three to four (4) month response time from receipt of full application

Typical DoD sponsors: CDMRP, GEIS

Individual DoD Sponsors

Air Force Office of Scientific Research (AFOSR)

As a part of the Air Force Research Laboratory (AFRL), AFOSR's technical experts foster and fund research within AFRL, universities, and industry laboratories to ensure the transition of research results to support USAF needs.

• To accomplish this task, AFOSR solicits proposals for research through various Broad Agency Announcements (BAAs) as well as various other programs outlined on their main webpage: http://www.wpafb.af.mil/afrl/afosr/
• AFOSR keeps specific requirements of each BAA up to date on Grants.gov.
  • You can search the site by typing organization name into the keyword field or using CFDA numbers 12.800, 12.630, and 12.910.

Congressionally Directed Medical Research Program 

Program areas are determined by Congress for each fiscal year.

 Global Emerging Infection Surveillance (GEIS) 

 The aim of the Global Emerging Infections Surveillance (GEIS) section at the Armed Forces Health Surveillance Branch (AFHSB) is to contribute to the protection of all DoD healthcare beneficiaries and the global community through an integrated worldwide emerging infectious disease surveillance system.

• Office of Naval Research (ONR)

• United States Army Medical Department Medical Research and Materiel Command (USAMRMC)

VPR Funding Mechanism 

New Faculty Hiring Packages and Start-Up Awards